Multiple p53-independent gene silencing mechanisms define the cellular response to p53 activation

Ramiro París1, Ryan E Henry, Sarah J Stephens

  • 1Department of Molecular, Cellular and Developmental Biology, University of Colorado at Boulder, Boulder, Colorado 80309-0347, USA.

Insights

Nutlin-3 treatment triggers varied cell fates in cancer, with p53 target gene expression differing. Cell type-specific mechanisms like mRNA degradation and DNA methylation control whether cells arrest or undergo apoptosis.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • The p53 tumor suppressor pathway is crucial for cancer treatment, but its activation by drugs like Nutlin-3 elicits diverse cellular responses.
  • Nutlin-3 inhibits MDM2, leading to p53 stabilization and target gene activation, yet outcomes like cell cycle arrest or apoptosis vary across cancer cell types.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying differential cellular responses to Nutlin-3 treatment in human cancer cells.
  • To identify key p53 target genes and regulatory pathways that dictate cell fate decisions (arrest vs. apoptosis) upon p53 activation.

Main Methods:

  • Comparative analysis of gene expression (p21, 14-3-3sigma, miR-34a) in HCT116 and BV173 cells treated with Nutlin-3.
  • Assessment of p53 binding to chromatin and coactivator recruitment across different cell types.
  • Investigation of post-transcriptional and epigenetic regulatory mechanisms (mRNA degradation, DNA methylation, microRNA processing).

Main Results:

  • Expression of p21, 14-3-3sigma, and miR-34a correlates with cell cycle arrest, while their silencing is observed in apoptotic cells.
  • miR-34a, p21, and 14-3-3sigma cooperate to counteract p53-induced apoptosis.
  • Cell type-specific gene silencing is mediated by enhanced p21 mRNA degradation, 14-3-3sigma promoter methylation, and reduced miR-34a processing, independent of p53 binding or coactivator recruitment.

Conclusions:

  • p53-independent regulatory events governing p53 target genes and microRNAs determine the cellular outcome of p53 activation.
  • Differential regulation of p21, 14-3-3sigma, and miR-34a expression is critical for cell fate decisions in response to Nutlin-3.
  • Targeting these downstream regulatory mechanisms could offer novel therapeutic strategies in cancer treatment.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Combinatorial Gene Control02:33

Combinatorial Gene Control

Combinatorial gene control is the synergistic action of several transcriptional factors to regulate the expression of a single gene. The absence of one or more of these factors may lead to a significant difference in the level of gene expression or repression.
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...